R&D Mini-Me? New Legal Questions for Organoids
Bill of Health
FEBRUARY 26, 2024
Much has been made of recently discussed CAR-T cell therapies for cancer , which have been around since 2017, and in-human sickle cell treatment Casgevy. In December 2022, the FDA Modernization Act 2.0 Would they classify as a medical device or biologic under FDA guidelines, or perhaps as a combination product?
111 
Let's personalize your content